| Basics |
|
Sutro Biopharma, Inc.
|
| IPO Date: |
October 12, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$73.78M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.27 | 3.45%
|
| Avg Daily Range (30 D): |
$0.13 | 5.67%
|
| Avg Daily Range (90 D): |
$0.07 | 4.47%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.43M |
| Avg Daily Volume (30 D): |
.68M |
| Avg Daily Volume (90 D): |
.65M |
| Trade Size |
| Avg Trade Size (Sh.): |
118 |
| Avg Trade Size (Sh.) (30 D): |
154 |
| Avg Trade Size (Sh.) (90 D): |
224 |
| Institutional Trades |
| Total Inst.Trades: |
643 |
| Avg Inst. Trade: |
$1.62M |
| Avg Inst. Trade (30 D): |
$2.02M |
| Avg Inst. Trade (90 D): |
$2.02M |
| Avg Inst. Trade Volume: |
.02M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.63M |
| Avg Closing Trade (30 D): |
$5.12M |
| Avg Closing Trade (90 D): |
$5.12M |
| Avg Closing Volume: |
16.04K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-2.6
|
$-.67
|
$-.14
|
|
Diluted EPS
|
$-2.6
|
$-.67
|
$-.14
|
|
Revenue
|
$ 105.65M
|
$ 9.69M
|
$ 63.75M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -216.77M
|
$ -56.86M
|
$ -11.5M
|
|
Operating Income / Loss
|
$ -185.58M
|
$ -48.46M
|
$ -3.35M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -108.65M
|
$ 1.9M
|
$ -42.2M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Dec 03, 2025:
1:10
|
|
|
|